Rohan P. Joshi

1. Tremelimumab and durvalumab as neoadjuvant or non-operative management strategy of patients with microsatellite instability-high resectable gastric or gastroesophageal junction adenocarcinoma: the INFINITY study by GONO
   2024/12/03 by A. Raimondi, Sara Lonardi, Sabina Murgioni +47 · 1 voice · 2 citations
   Medicine · #Cancer Immunotherapy and Biomarkers #Esophageal Cancer Research and Treatment #Gastric Cancer Management and Outcomes